Standard InChI: InChI=1S/C14H14N3O12PS2/c1-7-13(19)9(5-18)10(6-29-30(20,21)22)14(15-7)17-16-11-4-8(31(23,24)25)2-3-12(11)32(26,27)28/h2-5,19H,6H2,1H3,(H2,20,21,22)(H,23,24,25)(H,26,27,28)/b17-16+
Standard InChI Key: XYBQYEJAMIDMPT-WUKNDPDISA-N
Associated Targets(Human)
P2X purinoceptor 2 190 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
P2X purinoceptor 3 1991 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
P2X purinoceptor 7 5534 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
P2X purinoceptor 1 52 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
P2X purinoceptor 2 106 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
P2X purinoceptor 3 632 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
P2Y purinoceptor 1 470 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
P2X purinoceptor 1 68 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: No
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 511.38
Molecular Weight (Monoisotopic): 510.9757
AlogP: 1.43
#Rotatable Bonds: 8
Polar Surface Area: 250.41
Molecular Species: ACID
HBA: 11
HBD: 5
#RO5 Violations: 2
HBA (Lipinski): 15
HBD (Lipinski): 5
#RO5 Violations (Lipinski): 2
CX Acidic pKa: -3.24
CX Basic pKa:
CX LogP: -3.25
CX LogD: -7.35
Aromatic Rings: 2
Heavy Atoms: 32
QED Weighted: 0.15
Np Likeness Score: -0.10
References
1.Jacobson KA, Kim YC, Wildman SS, Mohanram A, Harden TK, Boyer JL, King BF, Burnstock G.. (1998) A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors., 41 (13):[PMID:9632352][10.1021/jm980183o]
2.Kim YC, Brown SG, Harden TK, Boyer JL, Dubyak G, King BF, Burnstock G, Jacobson KA.. (2001) Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors., 44 (3):[PMID:11462975][10.1021/jm9904203]
3.Jacobson KA, Jarvis MF, Williams M.. (2002) Purine and pyrimidine (P2) receptors as drug targets., 45 (19):[PMID:12213051][10.1021/jm020046y]
4.Jung KY, Moon HD, Lee GE, Lim HH, Park CS, Kim YC.. (2007) Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist., 50 (18):[PMID:17676725][10.1021/jm070114m]
5.Jung KY, Cho JH, Lee JS, Kim HJ, Kim YC.. (2013) Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists., 21 (9):[PMID:23510563][10.1016/j.bmc.2013.01.073]